CSIMarket
 
Heartbeam Inc   (BEAT)
Other Ticker:  
 
 
Price: $2.4100 $0.10 4.329%
Day's High: $2.55 Week Perf: 6.17 %
Day's Low: $ 2.27 30 Day Perf: 32.42 %
Volume (M): 156 52 Wk High: $ 3.74
Volume (M$): $ 377 52 Wk Avg: $2.06
Open: $2.30 52 Wk Low: $1.06



 Market Capitalization (Millions $) 64
 Shares Outstanding (Millions) 26
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -14
 Cash Flow (TTM) (Millions $) 13
 Capital Exp. (TTM) (Millions $) 0

Heartbeam Inc
Heartbeam Inc is a rapidly growing start-up that is focused on revolutionizing the healthcare industry. The company was founded in 2016 by a group of healthcare professionals and computer scientists who shared a common vision of improving patient care through the use of cutting-edge technology.

The core mission of Heartbeam Inc is to empower patients, providers, and payers to make informed healthcare decisions by leveraging real-time telemedicine and data analytics. The company offers a range of solutions that are designed to improve the quality of care while reducing costs.

One of the key factors that sets Heartbeam apart from other telemedicine providers is the company's proprietary platform, which has been specifically designed to be user-friendly, secure, and scalable. The platform leverages advanced data analytics and machine learning algorithms to provide personalized care solutions to patients, while also enabling real-time collaboration between healthcare providers.

Heartbeam's portfolio of services includes virtual consultations, remote monitoring, and personalized treatment plans. The company also offers an integrated electronic health record (EHR) system that allows healthcare providers to seamlessly manage patient data across different care settings.

Heartbeam has already made significant strides in the healthcare industry and has garnered a great deal of attention from investors and industry experts. The company has raised several rounds of funding from venture capital firms, and has been recognized for its innovative solutions by publications such as Forbes and VentureBeat.

Moving forward, Heartbeam plans to expand its reach and continue to innovate in the healthcare space. The company is committed to advancing the use of telemedicine and data analytics to improve patient outcomes and reduce costs, and is poised to make a significant impact in the years to come.


   Company Address: 2118 Walsh Avenue Santa Clara 95050 CA
   Company Phone Number: 899-4443   Stock Exchange / Ticker: NASDAQ BEAT
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Heartbeam Inc

BEAT Emerges as a Powerhouse in the Medical Equipment & Supplies Market, Shatters Expectations with Financial Q3 2023 Results

Heartbeam Inc, a relatively unknown player in the Medical Equipment & Supplies industry, recently released its earnings report for the third quarter of 2023. While lagging behind larger industry giants, Heartbeam's financial results for this period indicate a significant improvement compared to the previous year.
Heartbeam reported an operating shortfall of $-3.737 million for the third quarter of 2023. To put this in perspective, in the same quarter of the previous year, the organization recorded a slightly higher operating shortfall of $-3.61 million. However, the positive surprise lies in the fact that Heartbeam managed to reduce its losses to $-3.470 million, demonstrating progress towards the goal of becoming an industry leader.

Heartbeam Inc

BEAT Outshines Heartbeam Inc with Increasing Revenue Streams; Medical Equipment & Supplies Market Concerned as Heartbeam Reports Operating Shortfall for Q2 2023



The financial results of Heartbeam Inc in the second quarter of 2023 have generated significant interest within the Medical Equipment & Supplies industry. With an operating shortfall of -$3.312 million and no revenue mentioned for the April to June 2023 reporting season, stakeholders are eagerly awaiting the company's next strategic move. These figures overshadow the operating shortfall of -$3.535 million in the second quarter of 2022, indicating a critical situation at Heartbeam Inc. As emerging companies like BEAT demonstrate increased revenue streams, it is crucial for Heartbeam Inc to adopt cost-effective strategies to progress further.
Significant Financial Changes:
Heartbeam Inc's financial results reveal a notable shift in their losses compared to the previous year. In the second quarter of 2022, the company reported an operating shortfall of -$3.535 million. However, there has been a slight improvement in the most recent fiscal period, with losses reduced to -$3.154 million.

Heartbeam Inc

Heartbeam Inc's Operating Behavior Deteriorates Amidst First Quarter of 2023 Earnings Season2.

Heartbeam Inc, a Healthcare sector-based company, has recently announced its financial results for the first quarter of 2023, which ended on March 31st, 2023. Unfortunately, Heartbeam Inc recorded a cumulative net loss of $-15 million during the twelve-month period, resulting in a negative return on investment (ROI) of -282.91%. This was in sharp contrast to the overall progress seen in the sector, where 527 other companies had a higher return on investment in the same period.
Heartbeam Inc is experiencing challenges in revenue generation and profitability, as reflected in its financial statements for the first quarter of 2023. The company reported operating losses of $-4.156 million, a contraction from $-2.148 million in the first quarter of 2022. More significantly, however, the company is yet to report any revenue, making market participants anxious about its future prospects.






 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com